The trademark application ONETOUCH was filed by LifeScan IP Holdings, LLC, a Limited Liability Company (the "Applicant"). Application refused.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 25, 2024. Divisions of EUTM registrations of the trademark registration was recorded on April 9, 2024.
The Appeal with reference B R2090/2022-4 was Application partially rejected according to Article 7(1)(b) EUTMR with decision issued on March 22, 2023 by the EUIPO. The Refusal with reference B 018635056 was partially rejected according to Article 7(1)(b) EUTMR with decision issued on September 7, 2022 by the EUIPO.
Goods And Services
The mark was filed in class 9 with following description of goods:
Downloadable computer software for monitoring glucose levels and transmitting medical data
Downloadable computer software application for mobile devices, namely, software for diabetes management and glucose tracking
Downloadable computer software, namely, software for diabetes management and glucose tracking
Downloadable computer software, namely, software embedded within a glucose meter or a device which offers the user diabetes management suggestions and guidance based on current and previous glucose results and other tracked data
Downloadable mobile application to facilitate support and sharing of health information to patients living with diabetes and diabetes-related conditions
Downloadable mobile application to facilitate monitoring of health and wellness data to patients living with diabetes and diabetes-related conditions
Downloadable mobile application to facilitate interaction between users and coaches via video, text and direct interaction to patients living with diabetes and diabetes-related conditions.
The mark was filed in class 10 with Blood glucose meters and monitoring devices and blood glucose meter with embedded software which offers the user diabetes management suggestions and guidance on current and previous glucose results and other tracked data..